Biotech Specialty Pharma

Rubigo Therapeutics

1246 University Ave. W., Suite 211
St. Paul, MN 55104 United States
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Drug delivery system for skin cancer

Management Kevin Nickels, CEO; Stan Harpstead, CTO

Click here for Financial Data
Keywords: oncology, cancer, polymeric material, therapeutic molecule


Updated: Sept. 05, 2014


Rubigo Therapeutics is focused on obtaining market clearance of a proprietary drug delivery platform initially targeting skin cancer through the improved delivery of an existing FDA-cleared drug, Imiq......view more

Technology / Differentiation

The list of market opportunities and possible drug candidates that could be combined with the Rubigo Therapeutics unique material include several possibilities, the company has elected to focus its de...view more